Medical technology company NxStage Medical has secured CE mark approval for its next generation hemodialysis system.
This innovative system consists of new features and capabilities, including a new touchscreen user interface and integrated blood pressure monitor designed to enhance ease of use for patients performing home hemodialysis.
"Our next generation system was developed with extensive patient and customer feedback and builds on our decade long experience in providing life-changing therapy with the NxStage® System One™ to over 30 thousand patients in their homes around the world," said
"We are very excited to expand our portfolio and begin providing patients with new features and capabilities that are designed to significantly improve their therapy experience."
NxStage's next generation hemodialysis system is currently under review for 510(k) clearance from the
The NxStage System One is the first and only truly portable hemodialysis system cleared specifically by the
When combined with the NxStage PureFlow™ SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on-site on-demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate.
Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, including while they are sleeping – at home or on vacation and at a medically appropriate treatment frequency.
In addition, NxStage's Nx2me Connected Health® platform collects important NxStage System One and patient information for flexible viewing, monitoring and reporting that may improve patient management and patient retention, as well as simplify alternative site care.
The System One is also used to provide a range of flexible therapy options in more traditional care settings such as hospitals and dialysis centers.